(Q34609459)

3 August 2017

The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis (English)

1 reference

3 August 2017

0 references

Chen SS

1

1 reference

3 August 2017

Chen KK

2

1 reference

3 August 2017

Lin AT

3

1 reference

3 August 2017

Chang YH

4

1 reference

3 August 2017

Wu HH

5

1 reference

3 August 2017

Chang LS

6

1 reference

3 August 2017

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

89

1 reference

3 August 2017

710-713

1 reference

3 August 2017

7

1 reference

An exponential model relating censored survival data and concomitant information for prostatic cancer patients

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02733.X

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02733.X

Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02733.X

Effects of pituitary hormones on the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02733.X

Advanced carcinoma of the prostate- does the pre-treatment Leydig cell function determine the response to orchidectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02733.X

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02733.X

Prospective study of sex hormone levels and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02733.X

In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02733.X

10.1046/J.1464-410X.2002.02733.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference